M L Vandenplas
Overview
Explore the profile of M L Vandenplas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
311
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Turek M, Gogal Jr R, Saba C, Vandenplas M, Hill J, Feldhausser B, et al.
Res Vet Sci
. 2014 Mar;
96(2):304-7.
PMID: 24602916
Masitinib, a selective tyrosine kinase inhibitor, was investigated as a radiosensitizer in three primary feline injection-site sarcoma (ISS) cell lines. Sensitivity to masitinib was previously assessed via cell growth inhibition...
2.
Kwon S, Moore J, Robertson T, Hurley D, Wagner B, Vandenplas M
Vet Immunol Immunopathol
. 2013 Jul;
155(1-2):1-8.
PMID: 23820116
Although clinical evidence of endotoxemia has been associated with the development of acute laminitis in hospitalized horses with gastrointestinal diseases and endotoxins have been detected in the circulation of horses...
3.
Lawrence J, Saba C, Gogal Jr R, Lamberth O, Vandenplas M, Hurley D, et al.
Vet Comp Oncol
. 2012 Jan;
10(2):143-54.
PMID: 22236016
Dysregulation of platelet-derived growth factor receptor (PDGFR) may play a role in feline injection-site sarcoma (ISS) cell growth and viability. Masitinib, a tyrosine kinase inhibitor approved for treatment of canine...
4.
Figueiredo M, Salter C, Andrietti A, Vandenplas M, Hurley D, Moore J
Vet Immunol Immunopathol
. 2009 Apr;
131(1-2):65-72.
PMID: 19376596
Quantification of gene expression using real-time reverse transcription quantitative PCR (RT-qPCR) is a reliable method to monitor cellular responses to pro-inflammatory stimuli. The main objective of this study was to...
5.
Moore J, Norton N, Barton M, Hurley D, Reber A, Donovan D, et al.
Equine Vet J
. 2007 May;
39(3):243-8.
PMID: 17520976
Reasons For Performing Study: Endotoxaemia currently is associated with a poor prognosis in horses. The results of recent trials in other species indicate that phospholipid emulsions reduce the deleterious effects...
6.
Cohen N, Chaffin M, Vandenplas M, Edwards R, Nevill M, Moore J, et al.
Equine Vet J
. 2005 May;
37(3):212-6.
PMID: 15892228
Reasons For Performing Study: Prognosis of Rhodococcus equi pneumonia can be challenging because the course of the disease is often insidious and overt clinical signs are subtle. Early diagnosis is...
7.
Solberg O, Jackson K, Millon L, Stott J, Vandenplas M, Moore J, et al.
Vet Immunol Immunopathol
. 2004 Jan;
97(3-4):187-94.
PMID: 14741137
Three overlapping fragments of the equine interleukin-4 receptor alpha chain gene (IL4R) were cloned and sequenced. The resulting 3553 bp cDNA sequence exhibited homology to human, murine and bovine IL4R....
8.
Wooten M, Vandenplas M, Seibenhener M, Geetha T, Diaz-Meco M
Mol Cell Biol
. 2001 Nov;
21(24):8414-27.
PMID: 11713277
Atypical protein kinase C (PKC) isoforms are required for nerve growth factor (NGF)-initiated differentiation of PC12 cells. In the present study, we report that PKC-iota becomes tyrosine phosphorylated in the...
9.
Siriwardena A, Jorgensen M, Wolfert M, Vandenplas M, Moore J, Boons G
J Am Chem Soc
. 2001 Aug;
123(33):8145-6.
PMID: 11506583
No abstract available.
10.
Wooten M, Seibenhener M, Neidigh K, Vandenplas M
Mol Cell Biol
. 2000 Jun;
20(13):4494-504.
PMID: 10848576
The pathway by which atypical protein kinase C (aPKC) contributes to nerve growth factor (NGF) signaling is poorly understood. We previously reported that in PC12 cells NGF-induced activation of mitogen-activated...